Katie Riefski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Katie Riefski has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alexandra Ilacqua
Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
1 shared publication - Amber M. Aeilts
Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
1 shared publication - Julia Cooper
The Ohio State University
1 shared publication - Leigha Senter
Division of Human Genetics, Department of Internal Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
1 shared publication - Sue Friedman
Facing Our Risk of Cancer Empowered (FORCE), Tampa, FL, USA
1 shared publication
Latest Publications
- Open Access
- 27 June 2026
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 24 (1)
BRCAShare: a video-based message can increase sharing of familial genetic test results
Background: Genetic testing for known familial pathogenic or likely pathogenic germline variants in cancer susceptibility genes is central to identifying relatives at heightened risk for cancer. However, current data suggest that uptake of this practice referred to as “cascade testing” remains suboptimal. Research demonstrates that healthcare providers can alleviate barriers to cascade testing by providing informational resources to facilitate patient-mediated sharing of their genetic test results with their at-risk relatives. Methods: We recruited 103 individuals with a pathogenic or likely pathogenic variant in BRCA1 or BRCA2 (BRCA1/2). Participants were randomized to receive a family communication guide with or without a 2-minute video (BRCAShare) that describes the concept of a relative’s recent diagnosis of a harmful variant in BRCA1/2 , meant to facilitate sharing of results with relatives. All participants were given surveys to assess reactions to and impact of BRCAShare across three domains: (1) participants’ sharing of genetic information and intent to share genetic information; (2) perceived susceptibility to and seriousness of BRCA1/2 cancer related risks, benefits, or barriers to intrafamilial sharing of results and cascade testing; (3) the impact of family dynamic on sharing of genetic information. Results: The group given access to the BRCAShare video (guide + video) had significantly higher odds of reporting an intent to share and actual sharing with other family members compared to those who did not receive BRCAShare (guide only). Perceptions of cancer risk did not change significantly after viewing BRCAShare, however participants demonstrated strong understanding of risks and benefits of genetic testing at baseline. There was not a significant association between family dynamics and more intent to share. Conclusions: Our research suggests that this video message is a useful method for facilitating family sharing of BRCA1 / 2 results.
- 27 June 2026
- Published by Springer Nature in Hereditary Cancer in Clinical Practice
- Vol. 24 (1)
Open AccessBRCAShare: a video-based message can increase sharing of familial genetic test results
Background: Genetic testing for known familial pathogenic or likely pathogenic germline variants in cancer susceptibility genes is central to identifying relatives at heightened risk for cancer. However, current data suggest that uptake of this practice referred to as “cascade testing” remains suboptimal. Research demonstrates that healthcare providers can alleviate barriers to cascade testing by providing informational resources to facilitate patient-mediated sharing of their genetic test results with their at-risk relatives. Methods: We recruited 103 individuals with a pathogenic or likely pathogenic variant in BRCA1 or BRCA2 (BRCA1/2). Participants were randomized to receive a family communication guide with or without a 2-minute video (BRCAShare) that describes the concept of a relative’s recent diagnosis of a harmful variant in BRCA1/2 , meant to facilitate sharing of results with relatives. All participants were given surveys to assess reactions to and impact of BRCAShare across three domains: (1) participants’ sharing of genetic information and intent to share genetic information; (2) perceived susceptibility to and seriousness of BRCA1/2 cancer related risks, benefits, or barriers to intrafamilial sharing of results and cascade testing; (3) the impact of family dynamic on sharing of genetic information. Results: The group given access to the BRCAShare video (guide + video) had significantly higher odds of reporting an intent to share and actual sharing with other family members compared to those who did not receive BRCAShare (guide only). Perceptions of cancer risk did not change significantly after viewing BRCAShare, however participants demonstrated strong understanding of risks and benefits of genetic testing at baseline. There was not a significant association between family dynamics and more intent to share. Conclusions: Our research suggests that this video message is a useful method for facilitating family sharing of BRCA1 / 2 results.